| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |